Abstract
The tumour vasculature is vital for the establishment, growth and metastasis of solid tumours. Its physiological properties limit the effectiveness of conventional anti-cancer strategies. Therapeutic approaches directed at the tumour vasculature are reviewed, suggesting the potential of anti-angiogenesis and the targeting of vascular proliferation antigens as cancer treatments.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Baillie, C., Winslet, M. & Bradley, N. Tumour vasculature - a potential therapeutic target. Br J Cancer 72, 257–267 (1995). https://doi.org/10.1038/bjc.1995.323
Issue Date:
DOI: https://doi.org/10.1038/bjc.1995.323
- Springer Nature Limited
This article is cited by
-
Tumor blood flow change measured by CT perfusion during chemoradiation therapy (CRT) for monitoring response and predicting survival in patients with esophageal cancer
Esophagus (2014)
-
Mutant Bik expression mediated by the enhanced minimal topoisomerase IIα promoter selectively suppressed breast tumors in an animal model
Cancer Gene Therapy (2006)
-
The antitumour activity of 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF receptor-1 knockout mice
British Journal of Cancer (2002)
-
Inhibitory effect on expression of angiogenic factors by antiangiogenic agents in renal cell carcinoma
British Journal of Cancer (2002)
-
Microvessel density in chemosensitive and chemoresistant diffuse large B-cell lymphomas
Medical Oncology (2000)